MONTCLAIR, N.J., March 27, 2013 /PRNewswire/ -- CellHealth™ Institute (CHI), a new biotechnology company that provides breakthrough products, services and lifestyle education in the emerging category of personalized cell health has launched with the backing of key investors. John Malone Ph.D., chairman of Liberty Media Corporation (NASDAQ: LMCA) has invested $2 million in CellHealth Institute.
CellHealth Institute offers fully integrated and individualized health programs, paired with scientific biomarker evaluations, medical-grade supplements and informed advice for its clients and social community on healthy lifestyle choices to improve cell health. CellHealth Institute also provides advanced adult stem cell services, and has its own cell technology IP portfolio.
"The development of adult stem cell research and technology and the exciting progress in the world of cell health and regenerative medicine are the things that motivated me to invest in CellHealth Institute," said John Malone. "We know unequivocally that damage to human cells is at the core of most disease. We have a duty to research, develop and deliver to the doors of people across the United States and worldwide the products and services that can increase and enrich their quality of life. I believe that CellHealth Institute and the work of its team will lead us into the new frontier of preventative care and I'm excited to be a part of the progress that is being made."The support of investors, including Mr. Malone, will enable CellHealth Institute to grow its research and product development plans as well as its consumer-facing strategy. CellHealth Institute, which is led by cell health expert and Chief Medical Officer Dr. Vincent Giampapa, the world's first board-certified anti-aging physician, will also continue to collaborate with top-tier universities and publicly traded companies in its research of advanced adult stem cell treatments. "It is extremely gratifying to have John Malone, someone well recognized as having extraordinary business acumen with continuing success in many industries, so committed to our movement and the things we're trying to achieve," said David Saloff, chief executive officer of CellHealth Institute. "The concept of cell health is a new one to most people, but we want to ensure that it becomes widely understood and fast. The presence of exceptional visionaries like John Malone can only help us achieve our outreach with excellence." Mr. Malone is joined in support of CellHealth Institute by Ed Bosarge, founder and CEO of Capital Technologies Inc. Dr. Bosarge, through the Bosarge Family Office, has funded CellHealth Institute's latest clinical study into reprogramming aging adult stem cells at the University of Medicine and Dentistry New Jersey (UMDNJ). For more information, visit http://www.CellHealth.net. About CellHealth™ Institute CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including EveryCell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells. SOURCE CellHealth Institute
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV